# Carbetocin at Elective Cesarean Delivery Part 4

> **NCT02264769** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 110 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT02264769
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264769, "Carbetocin at Elective Cesarean Delivery Part 4". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02264769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*